Literature DB >> 1972042

Developmental expression of somatostatin in mouse brain. I. Immunocytochemical studies.

G Forloni1, C Hohmann, J T Coyle.   

Abstract

The postnatal development of the distribution of somatostatin immunoreactive (SOMLI) neurons and fibers in the forebrain of the Balb/C mouse and their relationship to cholinergic afferents have been examined. SOMLI was first discernable in the hypothalamus on postnatal day (PND) 3 and increased gradually to reach adult levels by PND 30. In the limbic system, SOMLI is detectable at birth. In all other structures of the forebrain, SOMLI could be observed by PND 3 but the distribution, density and morphology of the immunoreactive neurons evolved over the following 2-3 weeks. In general, SOMLI cells and fibers increased for 1-3 weeks after their initial appearance and subsequently declined to achieve adult levels. The distribution pattern of SOMLI elements in adult mouse brain was similar to previous reports in rat with a few notable differences in thalamus, olfactory structures and, to a lesser degree, cortex and hippocampus. The temporal pattern of SOMLI expression in extrahypothalamus forebrain regions, during development, suggests a role of this peptide in differentiation and synapse formation. Such an hypothesis receives further support from neonatal lesions of the basal forebrain which resulted in transient cortical cholinergic deafferentation, a delay of cortical differentiation and a transient increase in the number of SOMLI cells in cortex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972042     DOI: 10.1016/0165-3806(90)90120-n

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  12 in total

1.  Somatostatin presynaptically inhibits both GABA and glutamate release onto rat basal forebrain cholinergic neurons.

Authors:  Toshihiko Momiyama; Laszlo Zaborszky
Journal:  J Neurophysiol       Date:  2006-03-29       Impact factor: 2.714

2.  Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo.

Authors:  R L Neve; A Kammesheidt; C F Hohmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

3.  Neuronal overmaturation in dysraphism: ontogenic expression of neuropeptides in the fetal brain and developmental anomalies in exencephaly.

Authors:  S Oi; M Matsumae; O Sato; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1995-09       Impact factor: 1.475

4.  Somatostatin expression in TS16 mouse brain cultures.

Authors:  P Corsi; G Forloni; M Troia; T Lettini; J T Coyle
Journal:  J Mol Neurosci       Date:  1998-04       Impact factor: 3.444

5.  Ontogeny of somatostatin-immunoreactive systems in the brain of the brown trout (Teleostei).

Authors:  M Becerra; M J Manso; I Rodríguez-Moldes; R Anadón
Journal:  Anat Embryol (Berl)       Date:  1995-02

6.  Topography of Somatostatin Gene Expression Relative to Molecular Progenitor Domains during Ontogeny of the Mouse Hypothalamus.

Authors:  Nicanor Morales-Delgado; Paloma Merchan; Sylvia M Bardet; José L Ferrán; Luis Puelles; Carmen Díaz
Journal:  Front Neuroanat       Date:  2011-02-28       Impact factor: 3.856

Review 7.  Somatostatin, a Presynaptic Modulator of Glutamatergic Signal in the Central Nervous System.

Authors:  Anna Pittaluga; Alessandra Roggeri; Giulia Vallarino; Guendalina Olivero
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 6.208

8.  Multiple distinct subtypes of GABAergic neurons in mouse visual cortex identified by triple immunostaining.

Authors:  Yuri Gonchar; Quanxin Wang; Andreas Burkhalter
Journal:  Front Neuroanat       Date:  2008-03-28       Impact factor: 3.856

9.  Low-threshold spiking interneurons perform feedback inhibition in the lateral amygdala.

Authors:  Çağrı Temuçin Ünal; Bengi Ünal; M McLean Bolton
Journal:  Brain Struct Funct       Date:  2020-03-06       Impact factor: 3.270

Review 10.  Somatostatin-expressing neurons in cortical networks.

Authors:  Joanna Urban-Ciecko; Alison L Barth
Journal:  Nat Rev Neurosci       Date:  2016-05-26       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.